Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and ...

Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco ...

March 17 () - Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply ‌deal on Tuesday to co‑market ...

Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of semaglutide injection used for diabetes and weight management following the ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

India’s drug regulator has intensified checks on GLP-1 weight-loss drugs like semaglutide, targeting illegal sales, ...

Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI) had earlier provided ...

As part of the deal, Lupin will pay Zydus upfront licensing fees and milestone-based payments linked to predefined targets.